MAPS SPA (MAPS.MI) Stock Price & Overview

BIT:MAPS • IT0005364333

2.47 EUR
-0.16 (-6.08%)
Last: Mar 2, 2026, 07:00 PM

The current stock price of MAPS.MI is 2.47 EUR. Today MAPS.MI is down by -6.08%. In the past month the price decreased by -25.38%. In the past year, price decreased by -19.54%.

MAPS.MI Key Statistics

52-Week Range2.32 - 3.73
Current MAPS.MI stock price positioned within its 52-week range.
1-Month Range2.39 - 3.73
Current MAPS.MI stock price positioned within its 1-month range.
Market Cap
32.802M
P/E
16.47
Fwd P/E
8.18
EPS (TTM)
0.15
Dividend Yield
N/A

MAPS.MI Stock Performance

Today
-6.08%
1 Week
-18.75%
1 Month
-25.38%
3 Months
-28.20%
Longer-term
6 Months -13.03%
1 Year -19.54%
2 Years -13.94%
3 Years -28.41%
5 Years +15.96%
10 Years N/A

MAPS.MI Stock Chart

MAPS SPA / MAPS Daily stock chart

MAPS.MI Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to MAPS.MI. When comparing the yearly performance of all stocks, MAPS.MI is a bad performer in the overall market: 90.94% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
MAPS.MI Full Technical Analysis Report

MAPS.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to MAPS.MI. While MAPS.MI is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
MAPS.MI Full Fundamental Analysis Report

MAPS.MI Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
MAPS.MI Earnings History

MAPS.MI Forecast & Estimates

9 analysts have analysed MAPS.MI and the average price target is 5.22 EUR. This implies a price increase of 111.16% is expected in the next year compared to the current price of 2.47.

For the next year, analysts expect an EPS growth of -0.83% and a revenue growth 9.61% for MAPS.MI


Analysts
Analysts84.44
Price Target5.22 (111.34%)
EPS Next Y-0.83%
Revenue Next Year9.61%
MAPS.MI Forecast & Estimates

MAPS.MI Groups

Sector & Classification

MAPS.MI Financial Highlights

Over the last trailing twelve months MAPS.MI reported a non-GAAP Earnings per Share(EPS) of 0.15. The EPS increased by 68.09% compared to the year before.


Income Statements
Revenue(TTM)32.01M
Net Income(TTM)1.88M
Industry RankSector Rank
PM (TTM) 5.87%
ROA 3.12%
ROE 7.13%
Debt/Equity 0.35
Chartmill High Growth Momentum
EPS Q2Q%-2.54%
Sales Q2Q%17.72%
EPS 1Y (TTM)68.09%
Revenue 1Y (TTM)5.11%
MAPS.MI financials

MAPS.MI Ownership

Ownership
Inst Owners7.54%
Shares13.28M
Float5.10M
Ins Owners50.07%
Short Float %N/A
Short RatioN/A
MAPS.MI Ownership

MAPS.MI Competitors/Peers

The largest stocks on the EU markets in the "Application Software" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
1SAP SAP SE23.13194.699B
SAP SAP SE23.09192.719B
DSYA DASSAULT SYSTEMES SE13.2824.602B
DSY DASSAULT SYSTEMES SE13.2524.596B
NEM NEMETSCHEK SE28.197.819B
3E1 ELASTIC NV18.274.752B
AOF ATOSS SOFTWARE SE27.061.381B
PLNW PLANISWARE SA19.321.107B
74SW 74SOFTWARE SA13.56969.85M
1INN INNOSCRIPTA SE14.22748M
TMV TEAMVIEWER SE4.55731.499M
LSS LECTRA18.32721.796M
PSAN PSI SOFTWARE SE62.42709.64M

About MAPS.MI

Company Profile

MAPS logo image Maps SpA engages in the design, production, and distribution of software solutions for business big data analysis. The company is headquartered in Parma, Parma. The company went IPO on 2019-03-07. The firm develops technological solutions for the acquisition of information by extracting it from unstructured data and turning it into usable knowledge. The firm provides four products: Webdistilled, Clinika, Gzoom and Greennebula. Webdistilled is a semantic analysis system for marketing and communications agencies based on real-time marketing. Clinika is a semantics-based processing tool for clinical data to provide support for strategic and operational decision-making in the healthcare sector. Gzoom is a support for governance in public bodies and complex organizations. Greennebula is a cloud system for online management of environmental permits.

Company Info

MAPS SPA

via Paradigna 38/A

Parma PARMA IT

Employees: 120

MAPS Company Website

MAPS Investor Relations

Phone: 390521052300

MAPS SPA / MAPS.MI FAQ

Can you describe the business of MAPS SPA?

Maps SpA engages in the design, production, and distribution of software solutions for business big data analysis. The company is headquartered in Parma, Parma. The company went IPO on 2019-03-07. The firm develops technological solutions for the acquisition of information by extracting it from unstructured data and turning it into usable knowledge. The firm provides four products: Webdistilled, Clinika, Gzoom and Greennebula. Webdistilled is a semantic analysis system for marketing and communications agencies based on real-time marketing. Clinika is a semantics-based processing tool for clinical data to provide support for strategic and operational decision-making in the healthcare sector. Gzoom is a support for governance in public bodies and complex organizations. Greennebula is a cloud system for online management of environmental permits.


What is the stock price of MAPS SPA today?

The current stock price of MAPS.MI is 2.47 EUR. The price decreased by -6.08% in the last trading session.


Does MAPS SPA pay dividends?

MAPS.MI does not pay a dividend.


What is the ChartMill rating of MAPS SPA stock?

MAPS.MI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Can you provide the sector and industry classification for MAPS SPA?

MAPS SPA (MAPS.MI) operates in the Information Technology sector and the Software industry.


Is MAPS SPA (MAPS.MI) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MAPS.MI.


Can you provide the growth outlook for MAPS SPA?

The Revenue of MAPS SPA (MAPS.MI) is expected to grow by 9.61% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.